
A new study has found that Germany successfully attracts students from all over the world to its artificial intelligence doctoral programmes – but then loses many of them to other countries, particularly the US, Switzerland and the UK.
Stiftung Neue Verantwortung, a Berlin-based technology think tank, tracked the careers of 305 AI doctoral candidates who had been supervised by Germany’s leading AI researchers.













The United States remains the quickest country to get new medicines from clinical trial applications into patients, according to new data from the UK. 




A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.